-
Uncategorized1 month agoFormer FDA leaders, pharma speak out on mifepristone
After issuing a week-long pause on a federal appeals court decision to stop mail orders of the abortion medication mifepristone, the Supreme Court is expected to...
-
Uncategorized1 month ago
Trump plans to fire FDA chief Marty Makary: report
President Donald Trump has approved a plan to fire FDA Commissioner Marty Makary, M.D., according to a report from The Wall Street Journal.
-
Uncategorized1 month ago
FDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offering
🗓️ FDA delays subcutaneous Leqembi decision: Originally slated for later this month, the decision date now falls on August 24, Biogen and Eisai said. The agency...
-
Uncategorized1 month ago
ASGCT CEO David Barrett Previews the Upcoming Conference in Boston
ASGCT CEO David Barrett Previews the Upcoming Conference in Boston
-
Uncategorized1 month ago
ParcelBio Unveils Programmable mRNA Platform Backed by $13M Financing
ParcelBio Unveils Programmable mRNA Platform Backed by $13M Financing
-
Uncategorized1 month agoFDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended
Pierre Fabre claims to now be “aligned” with U.S. regulators on the path forward for a twice-rejected treatment. Elsewhere, Argenx swapped CEOs and Blackstone made a...
-
Uncategorized1 month agoRewriting the Oncology Playbook
Dr Mark Eccleston, Director of Inaphaea, discusses how patient-derived 3D models can bridge the translational divide in oncology. Drug development is a complex, costly, and time-consuming process with...
-
Uncategorized1 month agoSTAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to...
-
Uncategorized1 month agoASGCT Honors Mohamed Abou‑el‑Enein as Outstanding New Investigator
ASGCT Honors Mohamed Abou‑el‑Enein as Outstanding New Investigator
-
Uncategorized1 month ago
‘Pharma, not really’: Top young AI talent shuns careers at big drugmakers
RIO DE JANEIRO — Mazdak Abulnaga should be the poster child for the type of employee pharma companies want to hire this year. Abulnaga, a 33-year-old...
